CoChat

Levothyroxine replacement in primary congenital hypothyroidism: the higher the initial dose the higher the rate of overtreatment

Tuhan, Hale, Abaci, Ayhan, Cicek, Gizem, Anik, Ahmet, Catli, Gonul, Demir, Korcan, Bober, Ece · 2016 · Journal of Pediatric Endocrinology and Metabolism

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Congenital hypothyroidism (CH) is the most frequent endocrine disorder during the neonatal period, and a delay in diagnosis and treatment leads to irreversible complications. A high L-thyroxine (LT4) dose is recommended for treatment, while the optimal starting dose is still a matter of debate. The objective of this study was to determine the effects of various starting doses of LT4 on serum thyroid stimulating hormone (TSH) and thyroxine (fT4) at the end of the first month of treatment. A total of 71 patients (37 males, 52.1%) with CH were included in the study. The patients were designated into three sets of subgroups according to the following categorical variables: (i) The mean age of the study population was 22.3±13.2 days at diagnosis. At diagnosis, the mean fT4 was 0.84±0.32 ng/dL, and TSH was 39.3±30 μIU/mL. The mean initial dose of LT4 was 10.9±2.9 μg/kg/day. Overtreatment rates were significantly higher in the highest dose group (12–17 μg/kg/day) compared with the lowest dose group (6–9.9 μg/kg/day) (61.5% and 25%, respectively, p<0.05). None of the patients was undertreated. In this study, we found that the rate of overtreatment was significantly higher in patients who were given LT4 doses of 12–17 μg/kg/day. Thus, monitoring thyroid functions earlier than one month of treatment is necessary.

Overview

Integrity signals

Registry

Crossref · 10.1515/jpem-2015-0047

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 19

  1. Rose, 2006, of Section on Committee on Genetics AT Update of newborn screening and therapy for congenital hypothyroidism, American Academy Pediatrics, 117
  2. Selva, 2002, Initial treatment dose of thyroxine in congenital hypothyroidism, J Pediatr, 141
  3. Salerno, 2002, Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism, Thyroid, 12
  4. Rose, 2006, of Section on Committee on Genetics AT Update of newborn screening and therapy for congenital hypothyroidism, American Academy Pediatrics, 117
  5. Kumorowicz, Identification of deletions in children with congenital hypothyroidism and thyroid dysgenesis with the use of multiplex ligation - dependent probe amplification, J Pediatr Endocrinol Metab, 28, 2015
  6. Kempers, 2005, AS DA Disturbance of the fetal thyroid hormone state has long - term consequences for treatment of thyroidal and central congenital hypothyroidism, J Clin Endocrinol Metab, 4094, 10.1210/jc.2005-0197 · DOI · Paper page
  7. Daneman, 1980, Neonatal thyrotoxicosis intellectual impairment and craniosynostosis in later years, J Pediatr, 257, 10.1016/S0022-3476(80)80487-2 · DOI · Paper page
  8. Vaidyanathan, 2012, In congenital hypothyroidism an initial thyroxine dose of mug kg day is sufficient and sometimes excessive based on thyroid tests month later, J Pediatr Endocrinol Metab, 25, 10, 10.1515/jpem-2012-0025 · DOI · Paper page
  9. Campos, 1995, Outcome of lower thyroxine dose for treatment of congenital hypothyroidism, Clin Pediatr, 20, 514, 10.1177/000992289503401001 · DOI · Paper page
  10. Simoneau, 2004, and behavior at school entry in children with congenital hypothyroidism treated early with high - dose levothyroxine, Cognition J Pediatr, 144
  11. Bongers, 2013, de de de development in congenital hypothyroidism : is overtreatment a greater threat than undertreatment, Cognitive J Clin Endocr Metab, 4499, 10.1210/jc.2013-2175 · DOI · Paper page
  12. Delvecchio, 2007, Longitudinal assessment of levo - thyroxine therapy for congenital hypothyroidism : relationship with aetiology bone maturation and biochemical features, Horm Res, 12, 68
  13. Jones, 2008, Effect of high versus low initial doses of thyroxine for congenital hypothyroidism on thyroid function and somatic growth, Arch Dis Child, 940, 10.1136/adc.2007.120618 · DOI · Paper page
  14. Pearce, 2013, ETA Guideline management of subclinical hypothyroidism, Eur Thyroid, 28, 215, 10.1159/000356507 · DOI · Paper page
  15. Dubuis, 1996, Outcome of severe congenital hypothyroidism : closing the developmental gap with early high dose levothyroxine treatment, J Clin Endocr Metab, 222
  16. Tillotson, 1994, Relation between biochemical severity and intelligence in early treated congenital hypothyroidism : a threshold effect, Med, 309
  17. Fisher, 1989, DA Early treatment of congenital hypothyroidism, Pediatrics, 785, 10.1542/peds.83.5.785 · DOI · Paper page
  18. Fisher, 1983, DA Second International Conference on Neonatal progress report, Thyroid Screening J Pediatr, 653
  19. Bakker, 2002, Dynamics of the plasma concentrations of following thyroxine supplementation in congenital hypothyroidism, Clin Endocrinol, 529, 10.1046/j.1365-2265.2002.01632.x · DOI · Paper page

Cited by

See all 21

Metadata

Authors
Tuhan, H., Abaci, A., Cicek, G., Anik, A., Catli, G., Demir, K., & Bober, E.
Affiliations
Dokuz Eylül University (TR)
Venue
Journal of Pediatric Endocrinology and Metabolism
Published
2016-01-01
Volume
29
Issue
2
Pages
133-8
ISSN
  • 0334-018X (ISSN-L)
  • 2191-0251
OpenAlex
W2411210195
Cited by
21
References
20
Citations by year
2025: 1 · 2023: 2 · 2022: 7 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 1
FWCI
2.03
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Pediatric Endocrinology and Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • 54th Annual ESPE
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
primary congenital hypothyroidism, levothyroxine, initial dose, overtreatment, thyroid-stimulating hormone, free thyroxine, dyshormonogenesis, dysgenesis, thyroid function monitoring
MeSH terms
Congenital Hypothyroidism, Dose-Response Relationship, Drug, Female, Humans, Male, Thyroxine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.